Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 12 | 2 | 2 | 0 | €22.80 | €34.08 | 49.477% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.01 | €15.50 | 157.732% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €2.76 | €5.76 | 108.565% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Immunic Inc. | 6 | 2 | 1 | 2 | €1.15 | €5.48 | 375.026% |
| Avid Bioservices Inc | 2 | 0 | 1 | 0 | €6.30 | €8.75 | 38.889% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Valneva SE | 2 | 0 | 0 | 0 | €3.62 | €7.00 | 93.584% |
| Exact Sciences | 11 | 0 | 1 | 0 | €59.10 | €83.49 | 41.277% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €148.60 | €173.22 | 16.567% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €371.80 | €421.61 | 13.396% |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 0 | €10.60 | €21.39 | 101.821% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.93 | €22.78 | 108.374% |
| Personalis Inc | 5 | 0 | 1 | 0 | €1.29 | €3.23 | 149.521% |
| XOMA Corp. | 3 | 0 | 0 | 0 | €23.00 | €68.62 | 198.349% |
| aTyr Pharma Inc | 3 | 0 | 2 | 0 | €1.50 | €10.00 | 566.667% |
| United Therapeutics | 15 | 0 | 0 | 0 | €219.10 | €289.92 | 32.323% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Acorda Therapeutics Cdt | 14 | 0 | 1 | 0 | €0.47 | - | - |
| Precision BioSciences Inc | 6 | 0 | 1 | 0 | €0.35 | €2.81 | 706.293% |
| Taro Pharmaceutical Industries Ltd | 6 | 0 | 0 | 0 | €39.40 | - | - |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 7 | 1 | €847.40 | €957.22 | 12.960% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.75 | €19.86 | 245.477% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |